Azole Antifungal Resistance Today: Focus on Aspergillus (Q56837246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Azole antifungal resistance today: focus on Aspergillus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Malcolm Richardson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Riina Rautemaa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Paul Bowyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Caroline B Moore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Riina Rautemaa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

Current infectious disease reports

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

485-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

Modified response to ketoconazole of Candida albicans from a treatment failure

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Development of resistance in candida isolates from patients receiving prolonged antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Resistance of Candida species to fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Fungal pneumonia in patients with hematologic malignancies: current approach and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

The link between fungi and severe asthma: a summary of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Multidrug resistance in Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Our current understanding of fungal biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Aspergillus fumigatus biofilms in the clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0218-4

Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus

21 January 2018

1 reference

12 December 2020

Cryptic species and azole resistance in the Aspergillus niger complex.

1 reference

12 December 2020

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

1 reference

12 December 2020

Itraconazole resistance in Aspergillus fumigatus

1 reference

12 December 2020

Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.

1 reference

12 December 2020

10.1007/S11908-011-0218-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21931980%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference